Home › Funds › Rock Springs Capital Management LP › NAMS

Rock Springs Capital Management LP position in NAMS

NEWAMSTERDAM PHARMA COMPANY · Health Care

Rock Springs Capital Management LP reported holding 613,942 shares of NAMS (NEWAMSTERDAM PHARMA COMPANY) in its Q3 2026 13F filing — a position valued at US$14.9M, representing 0.81% of its reported portfolio and ranking #41 among its reported holdings. Rock Springs Capital Management LP has disclosed NAMS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)613.94K sh
Reported value held$14.93M
Portfolio Weight0.81%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's NAMS position evolved

Rock Springs Capital Management LP first disclosed a stake in NAMS in Q3 2024 at 353,319 shares (US$5.9M). The position peaked in Q2 2026 at 582,744 shares, worth US$19.7M. Across 9 filings, Rock Springs Capital Management LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 613,942 shares valued at US$14.9M — an increase of 31,198 shares quarter over quarter.. Notable position changes include a 117% increase in Q4 2024 (shares fell 19% over the following quarter), a 94% trim in Q3 2025 (shares rose 23% over the following quarter), a 1763% increase in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 353.32K $5.87M New
Q4 2024 767.52K $19.73M Add
Q1 2025 536.11K $10.97M Reduce
Q2 2025 536.11K $9.71M Hold
Q3 2025 31.60K $898.70K Reduce
Q4 2025 31.60K $1.11M Hold
Q1 2026 588.79K $18.85M Add
Q2 2026 582.74K $19.75M Reduce
Q3 2026 613.94K $14.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAMS and 13F data

NAMS (NEWAMSTERDAM PHARMA COMPANY) is a Health Care company. 40 other funds we track also report a position in NAMS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$613.0M), RA CAPITAL MANAGEMENT, L.P. (US$323.7M), FCPM III SERVICES B.V. (US$206.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAMS

All NAMS fund holders →

FAQ

How long has Rock Springs Capital Management LP held NAMS?

Rock Springs Capital Management LP has disclosed NAMS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Rock Springs Capital Management LP's current position in NAMS?

As of Q3 2026, Rock Springs Capital Management LP holds 613.94K shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), valued at $14.93M, representing 0.81% of its reported portfolio and ranking #41.

Has Rock Springs Capital Management LP been buying or selling NAMS?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in NAMS. The position peaked in Q2 2026 at 582.74K shares.

Which other funds hold NAMS?

Other major institutional holders of NAMS include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.